Mediatory effect of circulating vaspin on resting metabolic rate in obese individuals
详细信息 查看全文
- 作者：Sajjad Moradi ; Khadijeh Mirzaei ; Ahmed Abdulahi Abdurahman…
- 关键词：Vaspin ; Resting metabolic rate ; Obese ; Adipose tissue
- 刊名：European Journal of Nutrition
- 出版年：2016
- 出版时间：April 2016
- 年：2016
- 卷：55
- 期：3
- 页码：1297-1305
- 全文大小：637 KB
- 参考文献：1.Trayhurn P (2007) Adipocyte biology. Obes Rev 8(Suppl 1):41–44. doi:10.1111/j.1467-789X.2007.00316.x CrossRef
2.Clement K, Viguerie N, Poitou C, Carette C, Pelloux V et al (2004) Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18(14):1657–1669. doi:10.1096/fj.04-2204com CrossRef
3.Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S (2005) Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288(5):H2031–H2041. doi:10.1152/ajpheart.01058.2004 CrossRef
4.Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M et al (2006) Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 339(1):430–436. doi:10.1016/j.bbrc.2005.11.039 CrossRef
5.Velojić-Golubović M, Dimić D, Antić S, Radenković S, Đinđić B et al (2013) Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women: the effect of body weight reduction by caloric restriction. Vojnosanit Pregl 70(3):284–291CrossRef
6.Wohl P, Krušinová E, Hill M, Kratochvílová S, Zídková K et al (2010) Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose. Eur J Endocrinol 163(4):573–583CrossRef
7.Loffreda S, Yang S, Lin H, Karp C, Brengman M et al (1998) Leptin regulates proinflammatory immune responses. FASEB J 12(1):57–65
8.Balistreri CR, Caruso C, Candore G (2010) The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediat Inflamm 2010:802078. doi:10.1155/2010/802078 CrossRef
9.Yamawaki H (2011) Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses. Biol Pharm Bull 34(3):307–310CrossRef
10.Fu B-D, Yamawaki H, Okada M, Hara Y (2009) Vaspin can not inhibit TNF-alpha-induced inflammation of human umbilical vein endothelial cells. J Vet Med Sci 71(9):1201–1207CrossRef
11. Hida K, Wada J, Eguchi J, Zhang H, Baba M et al. (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102(30):10610–10615. doi:10.1073/pnas.0504703102 CrossRef
12.von Loeffelholz C, Mohlig M, Arafat AM, Isken F, Spranger J et al (2010) Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur J Endocrinol 162(3):507–513. doi:10.1530/eje-09-0737 CrossRef
13.Suleymanoglu S, Tascilar E, Pirgon O, Tapan S, Meral C et al (2009) Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Res Clin Pract 84(3):325–328. doi:10.1016/j.diabres.2009.03.008 CrossRef
14.de Luis DA, Sagrado MG, Aller R, Conde R, Izaola O (2010) Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle. Nutrition 26(11–12):1130–1133. doi:10.1016/j.nut.2008.11.019 CrossRef
15.Wada J (2008) Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 17(3):327–333. doi:10.1517/13543784.17.3.327 CrossRef
16.Kohan L, Zarei A, Fallahi S, Tabiee O (2014) Association between vaspin rs2236242 gene polymorphism and polycystic ovary syndrome risk. Gene 539(2):209–212. doi:10.1016/j.gene.2014.01.078 CrossRef
17.Bao JP, Jiang LF, Chen WP, Hu PF, Wu LD (2014) Expression of vaspin in the joint and the levels in the serum and synovial fluid of patients with osteoarthritis. Int J Clin Exp Med 7(10):3447–3453
18.Ozgen M, Koca SS, Dagli N, Balin M, Ustundag B et al (2010) Serum adiponectin and vaspin levels in rheumatoid arthritis. Arch Med Res 41(6):457–463. doi:10.1016/j.arcmed.2010.08.012 CrossRef
19.Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A (2009) Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 160(1):65–70. doi:10.1530/eje-08-0723 CrossRef
20.Choi SH, Kwak SH, Lee Y, Moon MK, Lim S et al (2011) Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin Endocrinol (Oxf) 75(5):628–635. doi:10.1111/j.1365-2265.2011.04095.x CrossRef
21.Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R et al (2011) Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Metabolism 60(4):544–549. doi:10.1016/j.metabol.2010.05.008 CrossRef
22.Yilmaz Y, Kurt R, Gurdal A, Alahdab YO, Yonal O et al (2011) Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 217(1):125–129. doi:10.1016/j.atherosclerosis.2011.03.026 CrossRef
23.Kukla M, Mazur W, Buldak RJ, Zwirska-Korczala K (2011) Potential role of leptin, adiponectin and three novel adipokines—visfatin, chemerin and vaspin—in chronic hepatitis. Mol Med 17(11–12):1397–1410. doi:10.2119/molmed.2010.00105
24.Li Q, Chen R, Moriya J, Yamakawa J, Sumino H et al (2008) A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity. J Int Med Res 36(4):625–629CrossRef
25.Johnstone AM, Murison SD, Duncan JS, Rance KA, Speakman JR (2005) Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine. Am J Clin Nutr 82(5):941–948
26.Do R, Bailey SD, Desbiens K, Belisle A, Montpetit A et al (2008) Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study. Diabetes 57(4):1147–1150. doi:10.2337/db07-1267 CrossRef
27.Loos RJ, Ruchat S, Rankinen T, Tremblay A, Pérusse L et al (2007) Adiponectin and adiponectin receptor gene variants in relation to resting metabolic rate, respiratory quotient, and adiposity-related phenotypes in the Quebec Family Study. Ame J Clin Nutr 85(1):26–34
28.Kang ES, Magkos F, Sienkiewicz E, Mantzoros CS (2011) Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans. Eur J Endocrinol 164(6):911–917. doi:10.1530/eje-11-0052 CrossRef
29.Analyzers TspBC (2015) BODY COMPOSITION ANALYZER; BC-418. Instruction Manual
30.Vandarakis D, Salacinski AJ, Broeder CE (2013) A comparison of COSMED metabolic systems for the determination of resting metabolic rate. Res Sports Med 21(2):187–194
31.Koiou E, Kalaitzakis E, Tziomalos K, Mavridis S, Dinas K et al (2011) Vaspin: a novel adipokine, member of the family of serine protease inhibitors. AUMJ 38:8–15
32.Youn B-S, Klöting N, Kratzsch J, Lee N, Park JW et al (2008) Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57(2):372–377CrossRef
33.Ye Y, Hou X-H, Pan X-P, Lu J-X, Jia W-P (2009) Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chin Med J 122(21):2530–2533
34.Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J et al (2008) Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 93(1):247–251CrossRef
35.Cura HS, Özdemir HH, Demir CF, Bulut S, İlhan N et al (2014) Investigation of vaspin level in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 23(3):453–456. doi:10.1016/j.jstrokecerebrovasdis.2013.03.023 CrossRef
36.Jung CH, Lee WJ, Hwang JY, Seol SM, Kim YM et al (2011) Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway. Biochem Biophys Res Commun 413(2):264–269. doi:10.1016/j.bbrc.2011.08.083 CrossRef
37.Mirzaei K, Hossein-Nezhad A, Keshavarz SA, Koohdani F, Saboor-Yaraghi AA et al (2013) Crosstalk between circulating peroxisome proliferator-activated receptor gamma, adipokines and metabolic syndrome in obese subjects. Diabetol Metab Syndr 5(1):79. doi:10.1186/1758-5996-5-79 CrossRef
38.Auguet T, Quintero Y, Riesco D, Morancho B, Terra X et al (2011) New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet 12(1):60. doi:10.1186/1471-2350-12-60 CrossRef
39.Hagedorn T, Poggiogalle E, Savina C, Coletti C, Paolini M et al (2012) Indirect calorimetry in obese female subjects: factors influencing the resting metabolic rate. World J Exp Med 2(3):58–64. doi:10.5493/wjem.v2.i3.58 CrossRef
40.Alawad AO, Merghani TH, Ballal MA (2013) Resting metabolic rate in obese diabetic and obese non-diabetic subjects and its relation to glycaemic control. BMC Res Notes 6:382. doi:10.1186/1756-0500-6-382 CrossRef
41.Sainz N, Barrenetxe J, Moreno-Aliaga MJ, Martinez JA (2015) Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism 64(1):35–46. doi:10.1016/j.metabol.2014.10.015 CrossRef
42.de Git KC, Adan RA (2015) Leptin resistance in diet-induced obesity: the role of hypothalamic inflammation. Obes Rev 16(3):207–224. doi:10.1111/obr.12243 CrossRef
43.Pannacciulli N, Bunt JC, Ortega E, Funahashi T, Salbe AD et al (2006) Lower total fasting plasma adiponectin concentrations are associated with higher metabolic rates. J Clin Endocrinol Metab 91(4):1600–1603. doi:10.1210/jc.2005-2271 CrossRef
44.Shoelson SE, Herrero L, Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132(6):2169–2180. doi:10.1053/j.gastro.2007.03.059 CrossRef
45.Phalitakul S, Okada M, Hara Y, Yamawaki H (2011) Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells. Pharmacol Res 64(5):493–500CrossRef
46.Li H, Peng W, Zhuang J, Lu Y, Jian W et al (2013) Vaspin attenuates high glucose-induced vascular smooth muscle cells proliferation and chemokinesis by inhibiting the MAPK, PI3K/Akt, and NF-κB signaling pathways. Atherosclerosis 228(1):61–68CrossRef
47.Coppack SW (2001) Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60(03):349–356CrossRef
48.Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Investig 100(11):2777CrossRef
49.Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A et al (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Investig 97(9):2152CrossRef
50.Mantzoros CS, Moschos S, Avramopoulos I, Kaklamani V, Liolios A et al (1997) Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans 1. J Clin Endocrinol Metab 82(10):3408–3413
51.Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E et al (1997) The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure 1. J Clin Endocrinol Metab 82(4):1293–1300
52.Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL (2002) Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 87(5):2391 CrossRef - 作者单位：Sajjad Moradi (1) (2)
Khadijeh Mirzaei (1)
Ahmed Abdulahi Abdurahman (1)
Seyed Ali Keshavarz (3)
Arash Hossein-nezhad (2) (4)
1. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences (TUMS), P.O. Box 14155-6117, Tehran, Iran
2. Osteoporosis Research Center, Endocrine Diseases and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences (TUMS), Tehran, Iran
4. Vitamin D, Skin, and Bone Research Laboratory, Section of Endocrinology, Nutrition, and Diabetes, Department of Medicine, Boston University Medical Center, Boston, MA, 02118, USA - 刊物类别：Chemistry and Materials Science
- 刊物主题：Chemistry
Nutrition - 出版者：Springer Berlin / Heidelberg
- ISSN：1436-6215
文摘
Background/objective Vaspin is a recently identified adipokine related to obesity and insulin sensitivity. The precise mechanism of vaspin in the body is not well known, and its function in resting metabolic rate (RMR) is even less understood. Therefore, the main aim of this study was to investigate the effect of circulating vaspin on RMR in obese people.